Therapeutic antibodies have been at the forefront of cancer treatment paradigms for over two decades, revolutionizing patient outcomes by harnessing the immune system’s power to attack malignant cells. Yet, despite their widespread use and clinical success, the precise molecular underpinnings that govern their therapeutic effectiveness have remained partially obscured. Much of this mystery has stemmed from the technical limitations inherent in studying antibody-receptor interactions at the nanoscale within living cells. Traditional imaging techniques have fallen short of resolving the complex receptor architectures that dictate functional antibody responses.

Addressing this critical gap, Jungmann’s team applied a novel microscopy technique named Resolution Enhancement by Sequential Imaging, or RESI. This cutting-edge approach enables visualization of single protein molecules on the cellular membrane with sub-nanometer resolution, a feat previously unattainable in intact cellular environments. By sequentially imaging orthogonally barcoded receptors and antibodies, RESI dissects their spatial arrangements with exquisite detail, revealing patterns that directly correspond to distinct therapeutic outcomes.

The focal point of their study was the CD20 receptor, a well-known therapeutic target expressed on B cells and implicated in various lymphomas and leukemias. Using high-throughput multi-target 3D RESI imaging, researchers meticulously mapped the nanoscale architecture of CD20 molecules and their complexes with two widely used anti-CD20 antibodies, Rituximab and Obinutuzumab. These antibodies differ subtly in their molecular design and clinical effects, yet until now, the structural basis of these differences remained elusive.

What emerged from their detailed imaging was a striking revelation: the way antibodies reorganize CD20 receptors on the cell surface dictates their downstream immune activation and tumor cell killing. Rather than simply binding receptors statically, therapeutic antibodies induce dynamic rearrangements, forming distinct nanoscale assemblies that influence signaling pathways and immune effector functions. This discovery challenges the prevailing simplistic models of antibody action and points to receptor pattern formation as a key determinant of therapeutic potency.

Isabelle Pachmayr, lead author of the study, articulates the transformative potential of these findings: “For the first time, we can directly visualize how structural modifications in antibody design translate into specific receptor clustering patterns and the resultant cellular responses. This insight provides a rational blueprint for engineering antibodies that elicit optimized therapeutic functions.” Her words underscore how molecular-level visualization bridges the gap between antibody structure and biological effect with unprecedented fidelity.

Beyond the compelling insights into CD20, this research heralds a new era of antibody biology by demonstrating the versatility and scalability of RESI technology. Unlike cryo-electron microscopy, which, while highly detailed, is labor-intensive and restricted to static, often non-physiological conditions, RESI operates in intact, living cells. This capability permits longitudinal studies of receptor dynamics and antibody effects in a context that closely mirrors the in vivo environment, vastly expanding the horizons of drug discovery.

The implications extend well beyond cancer immunotherapy. Because RESI can label and resolve virtually any membrane receptor with molecular specificity, it offers a powerful platform to interrogate a broad spectrum of therapeutic antibodies and receptor systems involved in autoimmune diseases, infectious diseases, and neurological disorders. The ability to map receptors and antibody interactions in three dimensions with sub-nanometer precision opens novel investigative pathways previously inaccessible.

Looking forward, the team envisions integrating RESI with multiplexed imaging of intracellular signaling molecules to construct comprehensive maps of immune activation cascades at the single-molecule level. This integrative approach promises to unravel complex therapeutic pathways, enabling scientists to pinpoint crucial molecular checkpoints and design therapies tailored to modulate these with exquisite accuracy.

Professor Jungmann reflects on this paradigm shift: “RESI unites structural biology with cellular physiology, providing a real-time window into the nanoscopic world where therapeutic outcomes are decided. This represents a quantum leap in our capacity to rationally design antibodies that can more effectively harness the immune system against cancer.” His statement encapsulates the transformative potential of this technology for immunotherapy research.

In sum, the innovative use of RESI imaging by Jungmann and colleagues breaks new ground in visualizing the elusive nanoscale mechanisms that underlie antibody function. By revealing how receptor organization within living cells governs the therapeutic activity of antibodies, this study charts a clear path toward engineering superior immunotherapies. As research continues to build on these findings, RESI may well become an indispensable tool in the global quest to develop more precise and potent treatments for cancer and beyond.

Subject of Research: The molecular and nanoscale organization of therapeutic antibody-receptor complexes in cancer immunotherapy using super-resolution imaging.

Article Title: Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI

News Publication Date: 23-Jul-2025

At the core of many physiological processes, and indeed pathological conditions, lies the mechanical behavior of cells and tissues. Mechanical cues regulate cellular function, influence tissue regeneration, and mediate disease progression. Traditionally, however, the study of such mechanics has been hampered by methodologies that often disrupt the very systems they aim to investigate. Techniques relying on physical contact, such as atomic force microscopy or micropipette aspiration, although powerful, are inherently invasive and limited in their ability to capture real-time dynamics within living systems. The BioBrillouin microscope circumvents these limitations by employing non-invasive optical methods that provide a comprehensive mechanical characterization without perturbing the sample.

The science behind Brillouin microscopy hinges on the interaction between photons and acoustic phonons within a material. When light passes through a medium, a fraction of it scatters due to the material’s intrinsic acoustic vibrations—phonons—resulting in an energy shift known as Brillouin scattering. This phenomenon yields rich data about the viscoelastic and compressibility properties of materials at a microscopic scale. By meticulously analyzing these subtle shifts in the frequency of scattered light, the BioBrillouin microscope maps the mechanical landscape of biological tissues with exquisite spatial resolution. Unlike other optical techniques, Brillouin microscopy uniquely captures both elastic and viscous components of tissue mechanics, providing more nuanced insight into cellular biomechanics.

Installed in the state-of-the-art Trinity Biomedical Sciences Institute and integrated within the Trinity Centre for Biomedical Engineering, the microscope currently operates under the supervision of Professor Michael Monaghan. The procurement and successful implementation of this system were made possible through generous funding from the European Research Council (ERC) and the Research Ireland initiative. Being the first commercial BioBrillouin microscope globally, the system benefits from robust technical collaboration with the manufacturer, CellSense Technologies GmbH, ensuring that Trinity’s researchers can explore the technology’s full potential while setting global benchmarks for its application.

Professor Monaghan, a prominent voice in this emerging field, contributed to an expert consensus article published recently in Nature Photonics, a leading journal in optical science. The paper consolidates interdisciplinary expertise and outlines the transformative promise of Brillouin microscopy in biological and material sciences. According to him, the microscope’s ability to non-invasively study live systems offers vital mechanobiological insights that are critical to elucidating complex disease mechanisms, including the genesis and progression of inflammation and cancer. Such insights could drive innovative diagnostic strategies and novel therapeutic interventions in biomedical research.

The application spectrum of Brillouin microscopy, however, extends far beyond biomedicine. The technology holds significant promise for expanding the frontiers of disciplines such as materials science, information and communications technology (ICT), energy storage, pharmaceuticals, and medical device development. In materials science, for instance, the microscope can probe the viscoelasticity and molecular interactions within polymers and composites under realistic conditions — an essential capability for the design of next-generation smart materials. Similarly, in ICT and energy sectors, understanding mechanical deformations at micro- and nano-scales can inform the durability and performance optimization of critical components.

Moreover, the non-contact, label-free nature of Brillouin microscopy is especially advantageous for longitudinal studies in dynamic biological systems. Researchers can monitor living cells and tissue samples over time to observe how mechanical properties evolve during processes such as differentiation, disease progression, or drug response, without the artifacts introduced by physical probing. This opens new horizons for developmental biology and pharmacology, where mechanical environment alterations are often subtle yet pivotal.

In tandem with the high technical sophistication, the introduction of BioBrillouin microscopy at Trinity is poised to attract a global community of scientists eager to leverage this unique capability. Already, international collaborations are taking shape, and visiting researchers have commenced utilizing the facility to advance their investigations. The collaborative environment, boosted by ERC and Research Ireland support, fosters cross-disciplinary innovations, bridging engineering, physics, biology, and medicine in unprecedented ways.

Importantly, the technology’s data-rich output is expected to synergize with emerging computational tools in machine learning and big data analytics. By integrating mechanical mapping with bioinformatics and molecular profiling, researchers can build comprehensive models of tissue behavior, disease etiology, and therapeutic effects. This confluence might accelerate the discovery pipeline from fundamental mechanobiology to clinical application, ensuring that discoveries generate meaningful health outcomes.

As the first commercial system of its kind, the Brillouin microscope at Trinity also serves as a platform for continuous technological refinement. Both hardware advancements and software enhancements are anticipated, refining sensitivity, resolution, and throughput—parameters crucial for integrating the microscope into routine research workflows. The close partnership between the academic researchers and the vendor exemplifies a model for successful technology transfer, translating cutting-edge innovation from conception to widespread academic and potentially clinical utility.

The scientific community’s embrace of this technology is a testament to its transformative potential. By enabling non-invasive, high-resolution mechanical characterization in live systems, BioBrillouin microscopy stands to reshape scientific paradigms concerning the interplay between mechanical forces and biological function. The prospect that researchers worldwide will travel to Trinity to access this instrument underscores the facility’s emerging status as a global hub for frontier mechanobiological research. This aligns perfectly with Trinity’s commitment to pioneering interdisciplinary science that tackles societally impactful challenges.

In summary, the arrival of the BioBrillouin microscope at Trinity College Dublin heralds a new era in mechanobiology and material science. This innovative technology unlocks the ability to visualize and quantify the mechanical properties of live biological systems and diverse materials without perturbation. Supported by major European funding, housed within a leading biomedical engineering environment, and equipped through global industry collaboration, this unique instrument is poised to accelerate discoveries in health, disease, and beyond. As researchers worldwide begin to unlock its capabilities, we can anticipate significant leaps forward that will expand scientific knowledge and drive technological progress across multiple disciplines.

Subject of Research: BioBrillouin microscopy and its applications in biomedical research, materials science, and related fields.

Article Title: [Not specified in the original content]

News Publication Date: [Not specified in the original content]

Web References:

• DOI link: http://dx.doi.org/10.1038/s41566-025-01681-6

References:

• Expert consensus paper published in Nature Photonics by Prof. Michael Monaghan and international collaborators.

Keywords:
Microscopy, Health and medicine, Cancer, BioBrillouin microscopy, Mechanobiology, Tissue mechanics, Non-invasive imaging, Biomedical engineering, Materials science, Inflammation, Developmental biology

The development of this imaging technique arises from the efforts of the Centre of Light for Life at the University of Adelaide. Under the guidance of Director Professor Kishan Dholakia, a leading expert in the field, the team set out to explore how cutting-edge camera technology can enhance the study of life sciences. These advanced cameras are unparalleled in their ability to count individual photons—the basic units of light—at each pixel, thus allowing researchers to examine biological specimens under conditions that replicate their natural environments.

Damaging living cells during imaging has long been a concern for biologists; however, with the advent of this new technology, the potential for harm is significantly reduced. Professor Dholakia states that gentle illumination with low levels of light is essential for accurately understanding living biological processes. “Damage from illumination is a real concern which can often be overlooked. Using the lowest level of light possible, together with these very sensitive cameras is important for understanding biology in live and developing cells,” he emphasized. This approach not only promotes the integrity of living tissues but also opens new dimensions for researchers studying embryonic development.

The research team, comprised of brilliant minds including Zane Peterkovic, Dr. Avinash Upadhya, Ramses Bautista Gonzalez, Dr. Megan Lim, Dr. Chris Perrella, Admir Bajraktarevic, and Associate Professor Kylie Dunning from the Robinson Research Institute, conducted pre-clinical trials to test the efficacy of this innovative imaging technology. Their findings, which were published in the esteemed journal APL: Photonics, reveal a promising future for this application in clinical settings, particularly in the realms of in vitro fertilization (IVF) and reproductive biology.

One of the remarkable outcomes of this research is the realization that fundamental concepts of physics, such as quantum mechanics, can serve as a powerful ally in enhancing digital imaging technology. Lead author and PhD student Zane Peterkovic notes, “Digital camera technology has advanced to the point where fundamental physics concepts like quantum mechanics become important and relevant,” emphasizing the unique intersection of physics and biological sciences. This blend of disciplines fosters deeper insights, ultimately contributing to broader implications for clinical practices and advancements in reproductive health.

In illuminating biological specimens, natural compounds within cells exhibit fluorescence, revealing substantial insights into their physiological properties. However, capturing these faint signals presents an ongoing challenge. Mr. Peterkovic explained that while the potential for bioluminescence is significant, the emitted signals are often weak. He expressed enthusiasm about applying quantum cameras to harness this delicate fluorescence: “It’s exciting to apply these quantum cameras and use it to get the most out of our microscopes.”

The endeavor involved developing a comprehensive methodology to compare image quality across varying camera technologies effectively. The intricate analysis required collaboration across a wide spectrum of expertise, ranging from optics and biology to laser physics and microscopy techniques. This multidisciplinary approach not only enhances the quality of imaging but also encourages the integration of advanced analytical methods.

The innovation doesn’t stop there; the team investigated how artificial intelligence could be employed to reduce noise from captured images. This static interference is a common challenge when cameras struggle to collect sufficient light. Mr. Peterkovic remarked, “These steps go beyond just putting the camera in the microscope to take pictures,” underscoring the depth of complexity involved in optimizing imaging techniques. Their work seeks not only to advance imaging technology but also to refine the interpretation of the biological data obtained.

Moving forward, the research team sees promising opportunities in the realm of quantum imaging, where manipulating quantum states of light could provide even deeper insights into biological samples. The potential for such advancements could revolutionize the way researchers perceive and understand living systems, pushing the boundaries of current scientific knowledge.

The impact of this research is not limited to academia; industry implications are also significant. By improving the imaging of live embryos, the findings may foster new pathways for clinical applications, especially in reproductive medicine. This could mean better outcomes for patients undergoing IVF treatments, as well as a more profound understanding of developmental biology as a whole.

Acknowledging the support received for this groundbreaking work, Professor Dholakia noted that funding from the Australian Research Council played a crucial role in facilitating the research project. Such collaborations highlight the importance of harnessing resources for scientific endeavors that promise to change the landscape of healthcare and biological research.

In summary, the University of Adelaide’s innovative approach to imaging live embryos using quantum measurement cameras marks a significant advancement in life sciences. By effectively combining the principles of quantum mechanics with cutting-edge imaging technology, the research team has opened new avenues for understanding the complexities of biological processes. As they continue to explore the true potential of these findings, the possibility of transformative breakthroughs in clinical practice and reproductive success becomes increasingly tangible.

Subject of Research: Cells
Article Title: Optimizing image capture for low-light widefield quantitative fluorescence microscopy
News Publication Date: 12-Mar-2025
Web References: DOI Link
References: APL: Photonics Journal
Image Credits: University of Adelaide

Keywords: Quantum imaging, low-light microscopy, biological imaging, fluorescence, IVF, embryology, Australian Research Council, optical technology, laser physics, artificial intelligence, reproductive biology.